Hospira Inc. recalls Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospi…

Recall date

April 21, 2017

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0862-2017

FDA classification

Class I

Brand / firm

Hospira Inc.

Sold / distributed

Nationwide in the USA and Puerto Rico

Why it was recalled

Presence of Particulate Matter: human hair found within an internal sample syringe.

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10